dilazep has been researched along with tetrodotoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, Y; Hara, A; Hashizume, H; Hoque, AN; Magishi, K | 1 |
| Abiko, Y; Arakawa, J; Hara, A; Hashizume, H | 1 |
2 other study(ies) available for dilazep and tetrodotoxin
| Article | Year |
|---|---|
A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cats; Dilazep; Enzyme Activation; Heart; Humans; In Vitro Techniques; Lysophosphatidylcholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phospholipases A; Phospholipases A2; Propranolol; Rats; Swine; Tetrodotoxin | 1997 |
Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: comparison with tetrodotoxin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dilazep; Energy Metabolism; In Vitro Techniques; Male; Myocardium; Palmitoylcarnitine; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tetrodotoxin; Vasodilator Agents; Ventricular Function, Left | 1997 |